United States · FDA National Drug Code directory
Niacin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62175-322_7e9530d1-a940-42e8-b754-0d4089b39db1
- Product NDC
- 62175-322
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Niacin
- Labeler
- Lannett Company, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170216
- Source listing expiry
- 20261231
Source-listed ingredients
- NIACIN — 1000 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (62175-322-43) · 62175-322-43
- 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (62175-322-46) · 62175-322-46
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →